Gf Fund Management »

Black Diamond Therapeutics shares owned by Gf Fund Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Gf Fund Management from 13F filings

Historical chart of Gf Fund Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Gf Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Gf Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7k 1.1k 2.43

More positions owned by Gf Fund Management

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOG)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Meta Platforms Common Stock (META)
Lumentum Holdings Common Stock (LITE)
Alphabet Common Stock (GOOGL)
PDD Holdings Adr (PDD)
Sandisk Corp Common Stock (SNDK)
Micron Technology Common Stock (MU)
Costco Wholesale Corp Common Stock (COST)
Palantir Technologies Common Stock (PLTR)

View all positions for Gf Fund Management

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Vanguard Group
Acadian Asset Management
Marshall Wace
Siren
Arrowstreet Capital, Limited Partnership
Jane Street
Renaissance Technologies
BlackRock
Vestal Point Capital
Dimensional Fund Advisors
Millennium Management
Connor, Clark & Lunn Investment Management
AWM Investment Company

View all funds holding Black Diamond Therapeutics